Coincident Fluorescence‐Burst Analysis of the Loading Yields of Exosome‐Mimetic Nanovesicles with Fluorescently‐Labeled Cargo Molecules
Source abstract
Abstract
Abstract The possible targeting functionality and low immunogenicity of exosomes and exosome‐like nanovesicles make them promising as drug‐delivery carriers. To tap into this potential, accurate non‐destructive methods to load them and characterize their contents are of utmost importance. However, the small size, polydispersity, and aggregation of nanovesicles in solution make quantitative characterizations of their loading particularly challenging. Here, an ad‐hoc methodology is developed based on burst analysis of dual‐color confocal fluorescence microscopy experiments, suited for quantitative characterizations of exosome‐like nanovesicles and of their fluorescently‐labeled loading. It is applied to study exosome‐mimetic nanovesicles derived from animal extracellular‐vesicles and human red blood cell detergent‐resistant membranes, loaded with fluorescently‐tagged dUTP cargo molecules. For both classes of nanovesicles, successful loading is proved and by dual‐color coincident fluorescence burst analysis, size statistics and loading yields are retrieved and quantified. The procedure affords single‐vesicle characterizations well‐suited for the investigation of a variety of cargo molecules and biological nanovesicle combinations besides the proof‐of‐principle demonstrations of this study. The results highlight a powerful characterization tool essential for optimizing the loading process and for advanced engineering of biomimetic nanovesicles for therapeutic drug delivery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Extracellular vesicles in disease · RNA Interference and Gene Delivery · MicroRNA in disease regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Applied Physics School of Engineering Sciences KTH Royal Institute of Technology Stockholm 10691 Sweden
Department of Clinical Sciences Swedish University of Agricultural Sciences (SLU) Uppsala 75007 Sweden
Oblique Therapeutics AB Gothenburg 41346 Sweden
Funding
Knut och Alice Wallenbergs Stiftelse · Vetenskapsrådet
References (57)
Show source-provided references
1. 10.1083/jcb.20121113810.1083/jcb.201211138 ↗
2. 10.1186/s13578-019-0282-210.1186/s13578-019-0282-2 ↗
3. 10.1021/acs.analchem.8b0183110.1021/acs.analchem.8b01831 ↗
4. 10.1007/s00432-018-02827-610.1007/s00432-018-02827-6 ↗
5. 10.1038/s41467-019-08895-710.1038/s41467-019-08895-7 ↗
6. 10.1021/acs.molpharmaceut.9b0010410.1021/acs.molpharmaceut.9b00104 ↗
7. 10.1021/acsomega.9b0135310.1021/acsomega.9b01353 ↗
8. 10.1021/acs.accounts.9b0010910.1021/acs.accounts.9b00109 ↗
9. 10.1021/acs.nanolett.8b0268910.1021/acs.nanolett.8b02689 ↗
10. 10.1038/nrd397810.1038/nrd3978 ↗
11. 10.4236/jbnb.2011.22506010.4236/jbnb.2011.225060 ↗
12. 10.1016/j.addr.2016.02.00610.1016/j.addr.2016.02.006 ↗
13. 10.1021/acsomega.0c0553910.1021/acsomega.0c05539 ↗
14. 10.7717/peerj.943410.7717/peerj.9434 ↗
15. 10.3390/ijms2019468410.3390/ijms20194684 ↗
16. 10.1080/07388551.2020.178538510.1080/07388551.2020.1785385 ↗
17. 10.3390/pharmaceutics1004021810.3390/pharmaceutics10040218 ↗
18. Kooijmans S. A. A. · Int. J. Nanomed. · 2012 · 7 · 1525
19. 10.1016/j.addr.2016.10.00410.1016/j.addr.2016.10.004 ↗
20. 10.1080/20013078.2017.142267610.1080/20013078.2017.1422676 ↗
21. 10.1021/acs.biomac.7b0117610.1021/acs.biomac.7b01176 ↗
22. 10.17980/2018.1310.17980/2018.13 ↗
23. 10.1021/acs.nanolett.9b0082410.1021/acs.nanolett.9b00824 ↗
24. 10.1038/s41467-018-04791-810.1038/s41467-018-04791-8 ↗
25. 10.1038/aps.2017.17810.1038/aps.2017.178 ↗
26. 10.1021/acsami.9b0482710.1021/acsami.9b04827 ↗
27. 10.7150/thno.2194510.7150/thno.21945 ↗
28. 10.1021/acs.chemrev.7b0053410.1021/acs.chemrev.7b00534 ↗
29. 10.3390/s1810317510.3390/s18103175 ↗
30. 10.1111/j.1538-7836.2010.04074.x10.1111/j.1538-7836.2010.04074.x ↗
31. 10.1016/j.aca.2017.11.06610.1016/j.aca.2017.11.066 ↗
32. 10.1038/467264b10.1038/467264b ↗
33. 10.1021/ac501801m10.1021/ac501801m ↗
34. 10.1039/C7NR08800K10.1039/C7NR08800K ↗
35. 10.1529/biophysj.106.08870810.1529/biophysj.106.088708 ↗
36. Widengren J. · Cell. Mol. Biol. · 1998 · 44 · 857
37. 10.1016/j.bpc.2019.10621810.1016/j.bpc.2019.106218 ↗
38. 10.1016/S0006-3495(97)78833-710.1016/S0006-3495(97)78833-7 ↗
39. 10.1038/nprot.2007.41010.1038/nprot.2007.410 ↗
40. 10.1530/REP-13-035810.1530/REP-13-0358 ↗
41. 10.1016/j.bbagen.2013.05.01910.1016/j.bbagen.2013.05.019 ↗
42. 10.1529/biophysj.105.06476610.1529/biophysj.105.064766 ↗
43. 10.1038/s41467-019-11574-210.1038/s41467-019-11574-2 ↗
44. 10.1007/s00216-020-02485-z10.1007/s00216-020-02485-z ↗
45. 10.1038/s41598-019-41800-210.1038/s41598-019-41800-2 ↗
46. 10.1016/j.biopha.2020.11044210.1016/j.biopha.2020.110442 ↗
47. 10.1021/acs.nanolett.9b0284110.1021/acs.nanolett.9b02841 ↗
48. 10.1096/fasebj.28.1_supplement.602.110.1096/fasebj.28.1_supplement.602.1 ↗
49. 10.1371/journal.pone.016071610.1371/journal.pone.0160716 ↗
50. 10.1021/ac052275910.1021/ac0522759 ↗
51. 10.1038/s41467-020-19468-410.1038/s41467-020-19468-4 ↗
52. 10.3390/molecules2414255710.3390/molecules24142557 ↗
53. 10.1021/ac980027p10.1021/ac980027p ↗
54. 10.1002/1361-6374(199609)4:3<149::AID-BIO5>3.0.CO;2-D10.1002/1361-6374(199609)4:3<149::AID-BIO5>3.0.CO;2-D ↗
55. 10.1002/chem.20090327210.1002/chem.200903272 ↗
56. 10.1016/j.impact.2020.10026110.1016/j.impact.2020.100261 ↗
57. 10.1111/j.1365-201X.1968.tb10873.x10.1111/j.1365-201X.1968.tb10873.x ↗